Phila.gov
At Prevention Point Philadelphia, officials report that interest in long-acting medications for opioid use disorder is growing significantly. The organization administered 312 Sublocade injections in fiscal year 2023 and double the number in fiscal year 2024.
Providers hope that raising awareness about this option will make addiction treatment accessible to even more people.
“When you don’t have to worry about taking something two or three times a day, especially if you’re unsheltered and have trauma and a number of other factors affecting your ability to take medication, the Sublocade is an amazing option,” said Silvana Mazzella, lead executive officer at Prevention Point.
